Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neuroone Medical Technologies (NMTC) Cost of Revenue (2020 - 2026)

Neuroone Medical Technologies filings provide 8 years of Cost of Revenue readings, the most recent being $216659.0 for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 7.75% to $216659.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $2.4 million, a 120.54% increase, with the full-year FY2025 number at $4.0 million, up 66.7% from a year prior.
  • Cost of Revenue hit $216659.0 in Q1 2026 for Neuroone Medical Technologies, up from $174157.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $1.2 million in Q3 2025 to a low of $38462.0 in Q2 2022.
  • Median Cost of Revenue over the past 5 years was $216659.0 (2026), compared with a mean of $403218.4.
  • Biggest five-year swings in Cost of Revenue: surged 904.21% in 2023 and later crashed 79.62% in 2025.
  • Neuroone Medical Technologies' Cost of Revenue stood at $126886.0 in 2022, then surged by 460.61% to $711335.0 in 2023, then plummeted by 71.19% to $204916.0 in 2024, then dropped by 15.01% to $174157.0 in 2025, then rose by 24.4% to $216659.0 in 2026.
  • The last three reported values for Cost of Revenue were $216659.0 (Q1 2026), $174157.0 (Q4 2025), and $1.2 million (Q3 2025) per Business Quant data.